| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(06)70383-8 |
| P698 | PubMed publication ID | 16439330 |
| P50 | author | Paula Brentlinger | Q46306162 |
| P2093 | author name string | Mark A Micek | |
| Christopher B Behrens | |||
| P2860 | cites work | Drugs for treating uncomplicated malaria in pregnant women | Q24246287 |
| Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. | Q30336129 | ||
| Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. | Q32179424 | ||
| Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial | Q33222370 | ||
| Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. | Q33929315 | ||
| Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis | Q34071371 | ||
| Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis | Q34093134 | ||
| The burden of malaria in pregnancy in malaria-endemic areas. | Q34292893 | ||
| Pharmacokinetic interactions of antimalarial agents | Q34296740 | ||
| A randomized trial of multivitamin supplements and HIV disease progression and mortality | Q34330475 | ||
| Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda | Q34359439 | ||
| Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. | Q34482190 | ||
| Cerebral malaria: optimising management | Q35078272 | ||
| Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa | Q35147242 | ||
| Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature | Q35721783 | ||
| The sick placenta-the role of malaria. | Q35744707 | ||
| Malaria associated pre-eclampsia in Senegal | Q46949538 | ||
| Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection | Q47380118 | ||
| No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients | Q47875301 | ||
| The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya | Q47923816 | ||
| The potential for interactions between antimalarial and antiretroviral drugs | Q48010230 | ||
| Fatal Toxic Epidermal Necrolysis During Prophylaxis With Pyrimethamine and Sulfadoxine in a Human Immunodeficiency Virus—Infected Person | Q59607020 | ||
| Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique | Q62494485 | ||
| Nevirapine-associated Stevens-Johnson syndrome | Q74282325 | ||
| Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression | Q77306403 | ||
| Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes | Q35824695 | ||
| Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy | Q35838600 | ||
| The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. | Q35872624 | ||
| Current issues in the treatment of uncomplicated malaria in Africa | Q35982644 | ||
| HIV drug nevirapine (Viramune): risk of severe hepatotoxicity | Q37091572 | ||
| Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease | Q37339874 | ||
| The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy | Q38882717 | ||
| Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. | Q38912058 | ||
| Anaemia prevention for reduction of mortality in mothers and children | Q38918951 | ||
| Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay? | Q38958299 | ||
| Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania | Q39000962 | ||
| Adverse events from drug therapy for human immunodeficiency virus disease | Q39424508 | ||
| Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial | Q39460339 | ||
| The WHO 'Roll Back Malaria Project': planning for adverse event monitoring in Africa | Q39465257 | ||
| Antiretrovirals as antimalarial agents. | Q39469775 | ||
| Post-neonatal infant mortality in Malawi: the importance of maternal health | Q39558012 | ||
| An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi | Q39558050 | ||
| Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study | Q39677595 | ||
| A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy | Q40501691 | ||
| Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors. | Q40568140 | ||
| Causes and empirical treatment of fever in HIV-infected adult outpatients, Abidjan, Côte d'Ivoire | Q40585852 | ||
| Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children | Q40589232 | ||
| Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis. | Q41915538 | ||
| The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. | Q41931847 | ||
| Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy | Q43653505 | ||
| Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine | Q43758891 | ||
| Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group | Q43836224 | ||
| Vitamin supplementation of HIV-infected women improves postnatal child growth | Q43948058 | ||
| Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality | Q43950013 | ||
| Determinants of low birth weight among HIV-infected pregnant women in Tanzania | Q43950680 | ||
| Nutritional factors and infectious disease contribute to anemia among pregnant women with human immunodeficiency virus in Tanzania | Q43951592 | ||
| Nelfinavir and nevirapine side effects during pregnancy | Q43987577 | ||
| Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya | Q44323711 | ||
| HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya | Q44394085 | ||
| Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial. | Q44959514 | ||
| Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects | Q45270618 | ||
| Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Tr | Q45772537 | ||
| Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS. | Q45779744 | ||
| Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study | Q46231235 | ||
| Unstable malaria transmission and maternal mortality--experiences from Rwanda | Q46351135 | ||
| Coma in Mozambican gravidas: causes and perinatal outcome | Q46367866 | ||
| Editorial: antifolates in prevention of HIV-associated opportunistic infections and in intermittent preventive treatment of malaria in Africa | Q46419601 | ||
| P433 | issue | 2 | |
| P921 | main subject | malaria | Q12156 |
| Sub-Saharan Africa | Q132959 | ||
| maternal health | Q6786626 | ||
| pregnancy-associated malaria | Q7239883 | ||
| P304 | page(s) | 100-111 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa | |
| P478 | volume | 6 |
| Q49431533 | A brief review on features of falciparum malaria during pregnancy |
| Q28469347 | A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women |
| Q37893776 | Consequences of HIV infection on malaria and therapeutic implications: a systematic review |
| Q34310322 | Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers |
| Q42249162 | Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial |
| Q34611300 | Eliminating preventable HIV-related maternal mortality in sub-Saharan Africa: what do we need to know? |
| Q38786988 | Experimental systems for studying Plasmodium/HIV coinfection |
| Q36717635 | From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy |
| Q33286064 | HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites |
| Q34171651 | HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytes |
| Q34228280 | Health literacy predicts pediatric dosing accuracy for liquid zidovudine. |
| Q37364317 | Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya. |
| Q35108721 | Interactions between malaria and HIV infections in pregnant women: a first report of the magnitude, clinical and laboratory features, and predictive factors in Kinshasa, the Democratic Republic of Congo |
| Q34404275 | Interactions between malaria and human immunodeficiency virus anno 2014 |
| Q35652102 | Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? |
| Q37084629 | Intermittent preventive treatment of malaria during pregnancy in central Mozambique |
| Q37048282 | Local illness concepts and their relevance for the prevention and control of malaria during pregnancy in Ghana, Kenya and Malawi: findings from a comparative qualitative study |
| Q41945000 | Malaria |
| Q37245300 | Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents |
| Q56355771 | Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies |
| Q44148263 | Malaria and pregnancy: a global health perspective. |
| Q33834841 | Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau |
| Q57076971 | Multilevel modelling of sociodemographic predictors of various levels of anaemia among women in Mali |
| Q36980850 | New approaches to pathogenesis of malaria in pregnancy. |
| Q35692279 | Parasitologic Assessment of Two-Dose and Monthly Intermittent Preventive Treatment of Malaria during Pregnancy with Sulphadoxine-Pyrimethamine (IPTP-SP) in Lagos, Nigeria |
| Q37491397 | Placental malaria, maternal HIV infection and infant morbidity. |
| Q41774697 | Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells. |
| Q40247417 | Prevalence of congenital malaria in newborns of mothers co-infected with HIV and malaria in Benin city |
| Q37809067 | Prevention and treatment of malaria in pregnancy |
| Q35938053 | Providing insecticide treated bed nets in antiretroviral treatment clinics in Malawi: a pilot study. |
| Q28475232 | Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania |
| Q36834927 | Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment |
| Q28538874 | Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial |
| Q37738205 | Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges |
| Q34622683 | Severe imported falciparum malaria among adults requiring intensive care: a retrospective study at the hospital for tropical diseases, London |
| Q36717638 | The economics of malaria in pregnancy--a review of the evidence and research priorities |
| Q42283606 | The effects of malaria and HIV co-infection on hemoglobin levels among pregnant women in Sekondi-Takoradi, Ghana. |
| Q35164569 | The prevalence of malaria among HIV seropositive individuals and the impact of the co- infection on their hemoglobin levels |
| Q39546704 | Treating malaria in pregnancy in developing countries: priorities in clinical research and drug development |
| Q34456393 | Treating severe malaria in pregnancy: a review of the evidence |
| Q24235994 | Treatment for anemia in people with AIDS |
Search more.